Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:32 am Purchase | 2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX | Adage Capital Management L.P. | 8,850,000 5.840% | 8,850,000 (New Position) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX | BlackRock Inc. BLK | 8,534,567 5.600% | 0 (Unchanged) | Filing History |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Heron Therapeutics, Inc. HRTX | BlackRock Inc. BLK | 8,534,567 5.600% | 1,497,253 (+21.28%) | Filing History |
| 2024-05-31 11:08 am Unchanged | 2023-11-14 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 26,713,503 17.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:37 pm Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | GREAT POINT PARTNERS LLC | 0 0.000% | -6,360,161 (Position Closed) | Filing History |
| 2024-02-14 4:21 pm Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | BAKER BROS. ADVISORS LP | 7,881,933 4.990% | -249,745 (-3.07%) | Filing History |
| 2024-02-14 08:46 am Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Capital, LP | 0 0.000% | -12,232,267 (Position Closed) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Heron Therapeutics, Inc. HRTX | The Vanguard Group | 8,338,912 5.560% | 532,627 (+6.82%) | Filing History |
| 2024-02-06 11:43 am Sale | 2023-12-31 | 13G | Heron Therapeutics, Inc. HRTX | FRANKLIN RESOURCES INC BEN | 6,404,795 4.300% | -5,462,985 (-46.03%) | Filing History |
| 2023-12-07 2:45 pm Sale | 2023-11-30 | 13G | Heron Therapeutics, Inc. HRTX | JPMORGAN CHASE & CO JPM | 84,549 0.000% | -6,669,080 (-98.75%) | Filing History |
| 2023-12-06 4:47 pm Sale | 2023-11-30 | 13G | Heron Therapeutics, Inc. HRTX | BlackRock Inc. BLK | 7,037,314 4.700% | -2,613,395 (-27.08%) | Filing History |
| 2023-07-25 4:13 pm Purchase | 2023-07-21 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 26,713,503 19.000% | 14,963,503 (+127.35%) | Filing History |
| 2023-04-13 1:58 pm Purchase | 2022-11-02 | 13G | Heron Therapeutics, Inc. HRTX | GREAT POINT PARTNERS LLC | 6,360,161 5.350% | 6,360,161 (New Position) | Filing History |
| 2023-02-22 4:24 pm Unchanged | 2023-02-21 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 11,750,000 9.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 5:42 pm Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | ArrowMark Colorado Holdings LLC | 3,560,848 3.000% | -2,845,017 (-44.41%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | TANG CAPITAL PARTNERS LP | 3,756,694 3.200% | -4,026,994 (-51.74%) | Filing History |
| 2023-02-13 07:29 am Sale | 2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | -8,275,000 (Position Closed) | Filing History |
| 2023-02-09 11:22 am Sale | 2022-12-30 | 13G | Heron Therapeutics, Inc. HRTX | The Vanguard Group | 7,806,285 6.570% | -1,802,760 (-18.76%) | Filing History |
| 2023-02-06 09:00 am Purchase | 2023-01-25 | 13D | Heron Therapeutics, Inc. HRTX | Rubric Capital Management LP | 11,750,000 9.900% | 11,750,000 (New Position) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | BlackRock Inc. BLK | 9,650,709 8.100% | 1,968,508 (+25.62%) | Filing History |